News from NASADAD

• NASADAD releases section-by-section analysis of overdose legislation by Senator Markey (D-MA)
• NASADAD releases section-by-section analysis of IMD legislation by Representative Fudge (D-OH)
• NASADAD attends Capitol Hill briefing on opioid use during pregnancy
• NASADAD signs on to a letter recognizing the importance of federal research funding

News from the States

• OhioMHAS releases November e-update

Around the Agencies

• Medicaid.gov expands and improves

Upcoming Events

• November 24^th:  Webinar on HIV and enrollment in the health insurance marketplace
• December 9^th: Webinar on screening and assessment for family engagement and retention

 

News from NASADAD

NASADAD releases section-by-section analysis of overdose legislation by Senator Markey (D-MA)

The legislation, the Opioid Overdose Reduction Act of 2014, S. 2092, was introduced by Sen. Edward Markey (D-MA) and co-sponsored by Sens. Kelly Ayotte (R-NH), Jay Rockefeller (D-WV), and Tim Kaine (D-VA). The legislation would extend civil liability protections to health care professionals who provide or prescribe naloxone, to individuals who distribute naloxone from an overdose prevention program, and to individuals who administer naloxone. State laws that are inconsistent with the above mentioned civil liability protections would be preempted, though State laws that provide additional protections would not. The legislation also provides a mechanism for States to opt out of its provisions.

NASADAD releases section-by-section analysis of IMD legislation by Representative Fudge (D-OH)

The legislation, the Breaking Addiction Act of 2014, H.R. 5136, was introduced by Rep. Marcia Fudge (D-OH) and originally co-sponsored by Reps. Tim Ryan (D-OH), Elijah Cummings (D-MD), Barbara Lee (D-CA), Eleanor Holmes Norton (D-DC), Cedric Richmond (D-LA), Alcee Hastings (D-FL), and Yvette Clarke (D-NY). The legislation would expand community treatment options by creating a 5-year demonstration project waiving the Institutions for Mental Diseases (IMD) Exclusion for those suffering from substance abuse. The IMD Exclusion originated in the 1965 Medicaid statute and was originally created so that patients receiving long-term, residential mental health services at a State psychiatric hospital would not be eligible to receive Medicaid coverage for that treatment. Substance use disorder treatment has been included in subsequent enacting legislation, thereby banning Medicaid reimbursement for residential treatment centers with more than 16 beds, which constitute a significant proportion of all residential treatment providers for substance use disorders. This makes it difficult for Medicaid beneficiaries to receive the residential substance use treatment services they need. When the pilot is completed, the bill directs the Secretary of the U.S. Department of Health and Human Services (HHS) to prepare a report to evaluate the impact of the program on a range of health care issues including costs, access to care, re-admissions, and emergency care.

NASADAD attends Capitol Hill briefing on opioid use during pregnancy

Shalini Wickramatilake-Templeman, Research Analyst attended the briefing, “Drug Exposure in Mothers and Newborns: Addressing Neonatal Abstinence Syndrome,” hosted by the March of Dimes Birth Defects Foundation (MDBDF) on November 19^th. The briefing featured remarks by Rep. Steve Stivers (R-OH) and Rep. Katherine Clark (D-MA) who co-sponsored the Coordinated Recovery Initiative for Babies (CRIB) Act which was introduced in June and seeks to increase research at the federal level on neonatal abstinence syndrome (NAS), including identification, treatment, and surveillance. Jennifer Conklin from Sen. Mitch McConnell’s (R-KY) office also provided remarks about a similar piece of legislation the Senator introduced called the Protecting Our Infants Act. Jessica Young of the American Congress of Obstetricians and Gynecologists (ACOG) gave an overview of NAS and the negative effects of punitive measures against pregnant women who use opioids, both medically and non-medically. Dr. Cecilia Spitznas of the Office of National Drug Control Policy (ONDCP) presented on ONDCP efforts related to NAS and Dr. Mark Hudak of the American Academy of Pediatrics provided an overview of the current body of research on NAS, including variability in symptoms and treatment options.

NASADAD signs on to a letter recognizing the importance of federal research funding

NASADAD was one of over 300 groups that signed on to a letter urging Congress to prioritize fiscal year 2015 budget appropriation legislation. The letter, published on November 12^th, 2014, was put together by the Ad Hoc Group for Medical Research and expressed the importance of bipartisan action to pass final, omnibus spending legislation by the end of the year. The omnibus, the group writes, should include appropriations that restore funding for the National Institutes of Health (NIH) to pre-sequestration levels. The group mentioned the importance of the research conducted and funded by NIH, and wrote that only through restored funding could NIH continue their record of excellence. NASADAD priority programs with NIH include the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

News from the States

OhioMHAS releases November e-update

The Ohio Department of Mental Health and Addiction Services (OhioMHAS) has released their November 2014 e-Update. The update includes a series of stories detailing Ohio’s progress in addiction and mental health services, beginning with a $10 million increase in funding for addiction recovery housing. Additionally, the update discusses the recent grant awarded to the University of Cincinnati to continue combating Hepatitis C among needle users. Finally, the update provides links to research publications, recent studies, and national news.

Around the Agencies

Medicaid.gov expands and improves

In time for the 2015 open enrollment period, Medicaid.gov has announced several improvements to the Medicaid website. The improved website is more streamlined, modern, and accessible. This means that consumer resources are more easily available through a Consumer Action page. Additionally, the Medicaid Moving Forward section has been remodeled to provide information about both Medicaid and the Children’s Health Insurance Program (CHIP). This section is coupled with expanded Medicaid and CHIP profiles for each state.

Upcoming Events

November 24^th:  Webinar on HIV and enrollment in the health insurance marketplace

The US Department of Health and Human Services (HHS) will host a webinar on Monday, November 24^th, 2014 from 2:00-2:45pm EST. The webinar, titled “Toward an AIDS-free Generation: Healthcare Outreach and Enrollment for People Living with HIV,” will discuss the critical relationship between the 2015 open enrollment period and the needs of the HIV community. This webinar, designed for service providers and community-based organizations, will also focus on the role of the Affordable Care Act in implementing the National HIV/AIDS Strategy and Viral Hepatitis Action Plan.

December 9^th: Webinar on screening and assessment for family engagement and retention

The New England Addiction Technology Transfer Center (ATTC) Network will host a webinar on Tuesday, December 9^th, 2014 from 1:00-2:30pm EST. The webinar will focus on effective strategies and practices for working with families with substance use disorders. This is the second webinar that will focus on screening and assessment targeted towards family engagement and retention. It will also explore effective methods of substance abuse treatment for parents at both a practice and systems level. Panelists will discuss the importance of expanding collaboration between States and stakeholders.